author-photo

Lothar Müller

Praxis

44

Papers

159

Citations

Citation Trend

Filter By

Papers (29) Sort By

Journal Conference Others

Changes in Treatment Reality and Survival of Patients With Advanced Clear Cell Renal Cell Carcinoma – Analyses From the German Clinical RCC-Registry

2018 Clinical Genitourinary Cancer
Show All
- Source
- Cite
- Save
Citations (12)
474PA novel biomarker combination and its association with resistance to chemotherapy combinations with bevacizumab: First results of the PERMAD trial

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
CabaGast: multicentre, Phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the esophagogastric junction and stomach

2018 Journal of Cancer Research and Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A novel biomarker combination and its association with resistance to chemotherapy combinations with bevacizumab: First results of the PERMAD trial.

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
4. Internationale Konsensuskonferenz zum fortgeschrittenen Mammakarzinom (ABC4), Lissabon, 04.11.2017: ABC4-Konsensus: Bewertung durch eine deutsche Expertengruppe

2018
Show All
- Source
- Cite
- Save
Citations (0)
Everolimus (RAD) as treatment in breast cancer patients with bone metastases only: Results of the phase II RADAR study.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Recurrent ovarian cancer and management of elderly patients: Results of a prospective trial of treosulfan focusing on patient's preference and clinical outcome (NOGGO-Preference-Study).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trial

2017 Journal of Geriatric Oncology
Show All
- Source
- Cite
- Save
Citations (5)
A multicentre, phase II study with cabazitaxel in previously treated patients with advanced or metastatic adenocarcinoma of the oesophagogastric junction and stomach (CABAGAST).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
902PPrognostic factors for overall survival of patients with advanced renal cell carcinoma – data from the German prospective RCC-Registry

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)